Compare FRSH & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRSH | INSP |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.2B |
| IPO Year | 2021 | 2018 |
| Metric | FRSH | INSP |
|---|---|---|
| Price | $8.56 | $67.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | $18.93 | ★ $127.40 |
| AVG Volume (30 Days) | ★ 5.0M | 1.3M |
| Earning Date | 02-10-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | N/A | ★ 1.48 |
| Revenue | $810,640,000.00 | ★ $882,622,000.00 |
| Revenue This Year | $18.20 | $15.34 |
| Revenue Next Year | $13.23 | $10.70 |
| P/E Ratio | ★ N/A | $44.51 |
| Revenue Growth | ★ 18.18 | 16.81 |
| 52 Week Low | $8.58 | $64.77 |
| 52 Week High | $18.78 | $197.75 |
| Indicator | FRSH | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 23.26 | 26.15 |
| Support Level | $10.46 | $77.75 |
| Resistance Level | $9.67 | $84.24 |
| Average True Range (ATR) | 0.52 | 4.61 |
| MACD | -0.27 | -1.20 |
| Stochastic Oscillator | 3.01 | 6.93 |
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.